Last reviewed · How we verify
NCT06875518
Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques.
NA trial testing BTLH with bilateral uterine artery ligation from its origin in Gynecologic Disease in 60 participants. Currently enrolling.
20 December 2025
Quick facts
| Lead sponsor | Mostafa Bahaa |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 12 March 2025 |
| Primary completion | 20 December 2025 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- BTLH with bilateral uterine artery ligation from its origin
- Conventional TLH
Conditions studied
- Gynecologic Disease — all drugs for Gynecologic Disease →
Sponsor
Mostafa Bahaa — full company profile →
Who can join
Adults 35 to 60, female only, with Gynecologic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Following Caesarean section, hysterectomy is the second most common major gynecological surgery, with approximately 600,000 procedures performed annually in the USA. Since Reich et al. first reported a total laparoscopic hysterectomy (TLH) in 1989, numerous studies have confirmed its feasibility and reproducibility. Evidence increasingly supports TLH over vaginal hysterectomy (VH) and total abdominal hysterectomy (TAH) for benign gynecological conditions. The development and rapid advancement of laparoscopic instruments and techniques have enabled the safe and successful completion of complex procedures using minimally invasive approaches. Women with a higher BMI or requiring complex surgeries benefit from reduced postoperative complications with laparoscopic operations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06875518
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gynecologic Disease
Currently open trials in the same condition.
- NCT07208383 — Awareness, Knowledge and Behavioral Seeking of Gynaecological Problems · recruiting
- NCT06826365 — Immune Cell Populations in the Endometrium · recruiting
- NCT07043322 — Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syn · Phase 2 · recruiting
- NCT07031921 — Ultrasound Image Bank: Advancing Medical Research and Diagnostics · recruiting
- NCT06820359 — Bowel Preparation in Minimally Invasive Gynecologic Surgery · NA · recruiting
Other Mostafa Bahaa trials
Trials by the same sponsor.
- NCT06995339 — Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese No · Phase 2 · recruiting
- NCT06924658 — Metformin in Safety and Efficacy in Gouty Patients · Phase 2 · recruiting
- NCT06762314 — Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes · Phase 2 · recruiting
- NCT06329882 — Doxycycline in Type II Diabetes · Phase 1, PHASE2 · recruiting
- NCT06301178 — Effect of Vitamin D Injection on Hypertrophic Scars and Keloids · Phase 1, PHASE2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06875518 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mostafa Bahaa
- Last refreshed: 24 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06875518.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing